• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

NEC X Invests in GPx to Advance AI-Driven Chronic Disease Monitoring

by Syed Hamza Sohail 11/13/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– NEC X, the Silicon Valley venture studio backed by NEC’s portfolio of advanced technologies and global businesses, today announced a new investment in General Prognostics Inc.

– (GPx), a fast-growing MedTech startup revolutionizing chronic disease monitoring and management.

NEC X Invests in GPx to Advance Remote Blood Monitoring Solution for Heart Failure Patients

NEC X has invested in GPx as part of its strategic effort to foster healthcare innovation and address pressing challenges in chronic disease management. This investment aligns with NEC X’s vision of leveraging technology to improve healthcare access and reduce system burdens, particularly for patients with chronic conditions.

Coinciding with this investment, GPx has joined the Elev X! Boost program, a venture initiative designed to scale ambitious startups through a tailored blend of capital, strategic partnerships, and integrations within NEC X’s expansive tech ecosystem. Through Elev X! Boost, GPx will:

– Enhance the accuracy of its flagship product, **CardioID**—the world’s first implant- and needle-free remote blood monitoring solution for heart failure patients.

– Drive revenue growth, enter new markets, and secure further funding.

The CardioID system enables remote monitoring by extracting biomarkers from wearable devices, utilizing data such as heart rate, heart rate variability, step count, and voice. Through advanced machine learning, these biomarkers are analyzed to develop predictive models with accuracy exceeding that of traditional implant-based systems.

GPx’s leadership team brings robust expertise in healthcare and medical devices. The team, composed of graduates from MIT and Harvard, includes co-founders **Sean Matsuoka** and Javier Echenique, whose backgrounds span leadership roles at firms like Caresyntax, M3, McKinsey & Company, Sony Corporation, Jana Care, Medtronic, and Volcano. Founding advisor Sidhant Jena also contributes significant experience, having co-founded and led Jana Care as CEO and held R&D leadership roles at Medtronic.

This partnership with NEC X will accelerate GPx’s growth trajectory as it prepares to scale operations and bring CardioID to market, setting new standards for non-invasive, real-time cardiac monitoring.

“GPx’s innovative approach to heart monitoring and chronic disease management is a perfect fit for the NEC Group’s vision of leveraging advanced technology to improve quality of life,” said Shintaro Matsumoto, President and CEO of NEC X. “By joining forces with GPx, we aim to enhance their predictive algorithms and capabilities. Together, we can transform the healthcare industry.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Chronic Disease Management

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |